|
1
|
Park JW, Kwon TK, Kim IH, et al: A new
strategy for the diagnosis of MAGE-expressing cancers. J Immunol
Methods. 266:79–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jheon S, Hyun DS, Lee SC, et al: Lung
cancer detection by a RT-nested PCR using MAGE A1-6 common primers.
Lung Cancer. 43:29–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jang SJ, Soria JC, Wang L, et al:
Activation of melanoma antigen tumor antigens occurs early in lung
carcinogenesis. Cancer Res. 61:7959–7963. 2001.PubMed/NCBI
|
|
4
|
van der Bruggen P, Traversari C, Chomez P,
et al: A gene encoding an antigen recognized by cytolytic T
lymphocytes on a human melanoma. Science. 254:1643–1647. 1991.
|
|
5
|
De Plaen E, Arden K, Traversari C, et al:
Structure, chromosomal localization, and expression of 12 genes of
the MAGE family. Immunogenetics. 40:360–369. 1994.PubMed/NCBI
|
|
6
|
Mecklenburg I, Stratakis DF, Huber RM, et
al: Detection of melanoma antigen-A expression in sputum and
bronchial lavage fluid of patients with lung cancer. Chest.
125:164S–166S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chaturvedi AK, Gaydos CA, Agreda P, et al:
Chlamydia pneumoniae infection and risk for lung cancer.
Cancer Epidemiol Biomarkers Prev. 19:1498–1505. 2010. View Article : Google Scholar
|
|
8
|
Pastorino U: Lung cancer screening. Br J
Cancer. 102:1681–1686. 2010. View Article : Google Scholar
|
|
9
|
Anglim PP, Alonzo TA and Laird-Offringa
IA: DNA methylation-based biomarkers for early detection of
non-small cell lung cancer: an update. Mol Cancer. 7:812008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yasufuku K: Early diagnosis of lung
cancer. Clin Chest Med. 31:39–47. 2010. View Article : Google Scholar
|
|
11
|
Sienel W, Varwerk C, Linder A, et al:
Melanoma associated antigen (MAGE)-A3 expression in stages I and II
non-small cell lung cancer: results of a multi-center study. Eur J
Cardiothorac Surg. 25:131–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Atanackovic D, Altorki NK, Cao Y, et al:
Booster vaccination of cancer patients with MAGE-A3 protein reveals
long-term immunological memory or tolerance depending on priming.
Proc Natl Acad Sci USA. 105:1650–1655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsuji T, Altorki NK, Ritter G, et al:
Characterization of preexisting MAGE-A3-specific CD4+ T
cells in cancer patients and healthy individuals and their
activation by protein vaccination. J Immunol. 183:4800–4808.
2009.PubMed/NCBI
|
|
14
|
Risch A and Plass C: Lung cancer
epigenetics and genetics. Int J Cancer. 123:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim H, Kim SJ, Lee SH, et al: Usefulness
of melanoma antigen (MAGE) gene analysis in tissue samples from
percutaneous needle aspiration biopsy of suspected lung cancer
lesions. Lung Cancer. 69:284–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng W, Blot WJ, Liao ML, et al: Lung
cancer and prior tuberculosis infection in Shanghai. Br J Cancer.
56:501–504. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kurasawa T: The coexistence of pulmonary
tuberculosis and lung cancer. Nihon Rinsho. 56:3167–3170.
1998.PubMed/NCBI
|
|
18
|
Olaussen KA, Soria JC, Park YW, et al:
Assessing abnormal gene promoter methylation in paraffin-embedded
sputum from patients with NSCLC. Eur J Cancer. 41:2112–2119. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim YT, Lee SH, Sung SW, et al: Can
aberrant promoter methylation of CpG islands predict the clinical
outcome of non-small cell lung cancer after curative resection? Ann
Thorac Surg. 79:1180–1188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim DS, Cha SI, Lee JH, et al: Aberrant
DNA methylation profiles of non-small cell lung cancers in a Korean
population. Lung Cancer. 58:1–6. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ulivi P, Zoli W, Calistri D, et al:
p16INK4A and CDH13 methylation in tumor and serum of non-small cell
lung cancer patients. J Cell Physiol. 206:611–615. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, An Q, Li L, et al: Methylation of
p16INK4a in Chinese lung cancer patients: biological and clinical
implications. Carcinogenesis. 24:1897–1901. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsu HS, Chen TP, Wen CK, et al: Multiple
genetic and epigenetic biomarkers for lung cancer detection in
cytologically negative sputum and a nested case-control study for
risk assessment. J Pathol. 213:412–419. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang B, O'Herrin SM, Wu J, et al: MAGE-A,
mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress
p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res.
67:9954–9962. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeon CH, Shin IH, Park JB, et al:
Prognostic significance of MAGE in peritoneal washes in gastric
carcinoma patients without peritoneal metastasis: results of a
5-year follow-up study. J Clin Gastroenterol. 44:682–686.
2010.PubMed/NCBI
|
